Merck’s PD-1 Drug Outperforms Ipilimumab for Treatment of Advanced Melanoma March 24, 2015December 14, 2022 Matthew Tontonoz
What Cancer Patients Need to Know About the Opdivo Approval March 13, 2015December 14, 2022 Emily Helck